Gendrel D, Raymond J, Moulin F, Iniguez J L, Ravilly S, Habib F, Lebon P, Kalifa G
Hôpital Saint Vincent de Paul, Paris, France.
Eur J Clin Microbiol Infect Dis. 1997 May;16(5):388-91. doi: 10.1007/BF01726370.
The aim of this study was to determine the etiologic agents associated with community-acquired pneumonia in 104 French children ages 18 months to 13 years. Potential respiratory pathogens were identified in 87 (85%) cases; these included respiratory syncytial virus in ten, other viruses in 20, Streptococcus pneumoniae in 14 and Mycoplasma pneumoniae (diagnosed by serologic procedures) in 43. Of 32 patients with Mycoplasma pneumoniae infection who were initially treated with beta-lactam antibiotics, 30 failed treatment. Recovery from mycoplasma infection occurred rapidly in patients treated with macrolide antibiotics (which included spiramycin in 31 patients, josamycin in 7, and erythromycin in 3); however, cough persisted in 12 patients for one month. The high frequency of Mycoplasma pneumoniae in children over 18 months of age must be considered when selecting an antibiotic for initial therapy.
本研究旨在确定104名年龄在18个月至13岁的法国儿童社区获得性肺炎的病原体。在87例(85%)病例中鉴定出潜在的呼吸道病原体;其中包括10例呼吸道合胞病毒、20例其他病毒、14例肺炎链球菌和43例肺炎支原体(通过血清学方法诊断)。32例最初接受β-内酰胺类抗生素治疗的肺炎支原体感染患者中,30例治疗失败。接受大环内酯类抗生素治疗的患者支原体感染恢复迅速(其中31例患者使用螺旋霉素、7例使用交沙霉素、3例使用红霉素);然而,12例患者咳嗽持续了1个月。在选择初始治疗抗生素时,必须考虑18个月以上儿童肺炎支原体感染的高发生率。